{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:49:54Z","timestamp":1765547394979,"version":"3.41.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Cutaneous leishmaniasis (CL) is a neglected tropical disease with diverse clinical manifestations, ranging from localized CL to severe forms such as diffuse CL and mucocutaneous leishmaniasis. Borderline disseminated CL (BDCL), an intermediate form, is characterized by multiple disseminated lesions and poses unique diagnostic and therapeutic challenges, especially in pediatric patients. This study explores pediatric BDCL to better understand its clinical presentation, diagnostic approaches and treatment outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We report 4 pediatric cases of BDCL from Panama, identified through polymerase chain reaction and histopathological analysis. Species identification utilized polymerase chain reaction and heat shock protein 70 gene sequencing. Treatment included amphotericin B, meglumine antimoniate and miltefosine, with follow-up evaluations assessing lesion progression and treatment outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>All patients exhibited multiple disseminated ulcerative and nodular lesions, with some involving mucosal sites. Species identification confirmed <jats:italic toggle=\"yes\">Leishmania guyanensis<\/jats:italic> and <jats:italic toggle=\"yes\">Leishmania panamensis<\/jats:italic> as causative agents. Two patients received meglumine antimoniate, achieving complete lesion resolution. Due to better tolerability, miltefosine was used in the remaining 2 patients, resulting in slower but complete lesion resolution over time. Amphotericin B demonstrated limited efficacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Pediatric BDCL presents significant diagnostic and therapeutic challenges due to variable immune responses, clinical presentations and species-related treatment resistance. While meglumine antimoniate and miltefosine showed promising results, amphotericin B was less effective. Further research is needed to establish optimized treatment protocols for pediatric BDCL, considering species-specific responses and pharmacokinetic and pharmacodynamic differences in children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004761","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:01:22Z","timestamp":1741633282000},"page":"e258-e264","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Borderline Disseminated (Intermediate) Cutaneous Leishmaniasis: A Case-based Approach to Diagnosis and Clinical Management in Pediatric Population"],"prefix":"10.1097","volume":"44","author":[{"given":"Jacqueline","family":"Levy","sequence":"first","affiliation":[{"name":"Hospital del Ni\u00f1o doctor Jos\u00e9 Ren\u00e1n Esquivel, Panama City, Panama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Estripeaut","sequence":"additional","affiliation":[{"name":"Hospital del Ni\u00f1o doctor Jos\u00e9 Ren\u00e1n Esquivel, Panama City, Panama"},{"name":"Sistema Nacional de Investigaci\u00f3n del SENACYT, Panama City, Panama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamilka","family":"Diaz","sequence":"additional","affiliation":[{"name":"Gorgas Memorial Institute of Health Studies, Panama City, Panama"},{"name":"Interamerican University of Panama, Panama City, Panama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica R.","family":"Pachar Flores","sequence":"additional","affiliation":[{"name":"Hospital Santo Tom\u00e1s, Servicio de Infectologia, Panama City, Panama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Garcia-Redondo","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Lozano-Dur\u00e1n","sequence":"additional","affiliation":[{"name":"Hospital Universitario Costa del Sol de Marbella, Marbella, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan D.","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Su\u00e1rez","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Infectotropico, Panama City, Panama"},{"name":"Laboratory of Immunology, University of Panama, Panama City, Panama."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1259-1736","authenticated-orcid":false,"given":"Alberto","family":"Paniz-Mondolfi","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"R1-20250613","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41597-020-0451-5","article-title":"An interactive database of Leishmania species distribution in the Americas.","volume":"7","author":"Herrera","year":"2020","journal-title":"Sci Data"},{"key":"R2-20250613","doi-asserted-by":"crossref","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies [published correction appears in PLoS Negl Trop Dis. 2016 Jun 2;10(6):e0004770. doi: 10.1371\/journal.pntd.0004770].","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"key":"R3-20250613","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ijd.13664","article-title":"American cutaneous leishmaniasis in infancy and childhood.","volume":"56","author":"Paniz-Mondolfi","year":"2017","journal-title":"Int J Dermatol"},{"key":"R4-20250613","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-4632.2012.05709.x","article-title":"Intermediate\/borderline disseminated cutaneous leishmaniasis.","volume":"52","author":"Paniz Mondolfi","year":"2013","journal-title":"Int J Dermatol"},{"key":"R5-20250613","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0074-02762004000300001","article-title":"Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review.","volume":"99","author":"Silveira","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R6-20250613","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5334\/aogh.4409","article-title":"Malnutrition among children under age five in Panama: results of the ENSPA 2019.","volume":"90","author":"Pedreschi","year":"2024","journal-title":"Ann Glob Health"},{"year":"2023","key":"R7-20250613","article-title":"World Health Organization Factsheets Leishmaniasis."},{"key":"R8-20250613","doi-asserted-by":"crossref","first-page":"e0006986","DOI":"10.1371\/journal.pntd.0006986","article-title":"Interventions to treat cutaneous leishmaniasis in children: a systematic review.","volume":"12","author":"Uribe-Restrepo","year":"2018","journal-title":"PLoS NeglTrop Dis"},{"key":"R9-20250613","doi-asserted-by":"crossref","first-page":"e0065221","DOI":"10.1128\/Spectrum.00652-21","article-title":"Development of an amplicon-based next-generation sequencing protocol to identify Leishmania species and other trypanosomatids in leishmaniasis endemic areas.","volume":"9","author":"Pati\u00f1o","year":"2021","journal-title":"Microbiol Spectr"},{"key":"R10-20250613","doi-asserted-by":"crossref","first-page":"110712","DOI":"10.1016\/j.nut.2019.110712","article-title":"Nutrition, malnutrition, and leishmaniasis.","volume":"73","author":"Nweze","year":"2020","journal-title":"Nutrition"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0625.2002.110104.x","article-title":"Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterization of the lesion.","volume":"11","author":"Diaz","year":"2002","journal-title":"Exp Dermatol"},{"key":"R12-20250613","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1590\/S0074-02762005000500013","article-title":"Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis.","volume":"100","author":"Silveira","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R13-20250613","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The clinical and immunological spectrum of American cutaneous leishmaniasis.","volume":"87","author":"Convit","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R14-20250613","doi-asserted-by":"crossref","first-page":"2603730","DOI":"10.1155\/2019\/2603730","article-title":"Cutaneous leishmaniasis: the complexity of host\u2019s effective immune response against a polymorphic parasitic disease.","volume":"2019","author":"Gabriel","year":"2019","journal-title":"J Immunol Res"},{"key":"R15-20250613","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4269\/ajtmh.20-1336","article-title":"Molecular identification of parasites causing cutaneous leishmaniasis in Panama.","volume":"104","author":"Miranda","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"R16-20250613","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.","volume":"46","author":"Llanos-Cuentas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R17-20250613","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","article-title":"Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.","volume":"195","author":"Arevalo","year":"2007","journal-title":"J Infect Dis"},{"key":"R18-20250613","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.","volume":"195","author":"Cruz","year":"2007","journal-title":"J Infect Dis"},{"key":"R19-20250613","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4269\/ajtmh.2011.10-0002","article-title":"Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.","volume":"84","author":"Layegh","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"R20-20250613","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species.","volume":"64","author":"Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"R21-20250613","doi-asserted-by":"crossref","first-page":"e02198","DOI":"10.1128\/AAC.02198-16","article-title":"Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis.","volume":"61","author":"Castro","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-20250613","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00292-12","article-title":"Optimal dosing of miltefosine in children and adults with visceral leishmaniasis.","volume":"56","author":"Dorlo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-20250613","doi-asserted-by":"crossref","first-page":"e15706","DOI":"10.1111\/dth.15706","article-title":"Treatment of pediatric cutaneous leishmaniasis with liposomal amphotericin B.","volume":"35","author":"Erat","year":"2022","journal-title":"Dermatol Ther"},{"key":"R24-20250613","doi-asserted-by":"crossref","first-page":"ofad348","DOI":"10.1093\/ofid\/ofad348","article-title":"Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis.","volume":"10","author":"Chivinski","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R25-20250613","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1468-3083.2011.04070.x","article-title":"A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis.","volume":"26","author":"Motta","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R26-20250613","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/AAC.33.11.1989","article-title":"Pharmacokinetics of amphotericin B in children.","volume":"33","author":"Benson","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-20250613","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults.","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"key":"R28-20250613","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4269\/ajtmh.19-0531","article-title":"Clinical presentation and response to therapy in children with cutaneous leishmaniasis.","volume":"102","author":"Suprien","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"R29-20250613","doi-asserted-by":"crossref","first-page":"e0196247","DOI":"10.1371\/journal.pone.0196247","article-title":"Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia.","volume":"13","author":"Franco-Mu\u00f1oz","year":"2018","journal-title":"PLoS One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004761","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:04:00Z","timestamp":1749852240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004761","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"type":"print","value":"0891-3668"},{"type":"electronic","value":"1532-0987"}],"subject":[],"published":{"date-parts":[[2025,3,5]]}}}